ArticleFrontiers in neurology
Mechanomyography as a novel marker of nerve dysfunction and recovery in chronic entrapment neuropathy.
Article in Frontiers in neurology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: There is a need for objective metrics to quantify the degree of nerve dysfunction resulting from chronic entrapment neuropathy. Mechanomyography (MMG) detects mechanical motor activity after nerve stimulation using accelerometry, and it may be a useful tool for quantifying nerve function. Compared to traditional electrodiagnostic testing, MMG offers practical advantages including resistance to electrical interference and non-invasive sensor placement. The aim of this study was to investigate the association between MMG and nerve dysfunction secondary to chronic nerve compression in a rodent model, comparing these results to established electrodiagnostic and histologic metrics. Methods: Lewis rats ( Results: Compared across all timepoints, compressed nerves had increased MMG-st (control: 0.32 ± 0.09 mA, compressed: 0.42 ± 0.11 mA, Discussion: MMG-st was elevated after compression and improved following decompression, with statistically significant correlations to other established metrics. These results support a potential role for MMG in chronic entrapment neuropathies as an objective biomarker for quantifying nerve dysfunction and monitoring decompression adequacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.